FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023244494> ?p ?o ?g. }

• W2023244494 endingPage "e100777" @default.
• W2023244494 startingPage "e100777" @default.
• W2023244494 abstract "Inhibition of sodium glucose cotransporter 2 (SGLT2) has been reported as a new therapeutic strategy for treating diabetes. However, the effect of SGLT2 inhibitors on the kidney is unknown. In addition, whether SGLT2 inhibitors have an anti-inflammatory or antioxidative stress effect is still unclear. In this study, to resolve these issues, we evaluated the effects of the SGLT2 inhibitor, dapagliflozin, using a mouse model of type 2 diabetes and cultured proximal tubular epithelial (mProx24) cells. Male db/db mice were administered 0.1 or 1.0 mg/kg of dapagliflozin for 12 weeks. Body weight, blood pressure, blood glucose, hemoglobin A1c, albuminuria and creatinine clearance were measured. Mesangial matrix accumulation and interstitial fibrosis in the kidney and pancreatic β-cell mass were evaluated by histological analysis. Furthermore, gene expression of inflammatory mediators, such as osteopontin, monocyte chemoattractant protein-1 and transforming growth factor-β, was evaluated by quantitative reverse transcriptase-PCR. In addition, oxidative stress was evaluated by dihydroethidium and NADPH oxidase 4 staining. Administration of 0.1 or 1.0 mg/kg of dapagliflozin ameliorated hyperglycemia, β-cell damage and albuminuria in db/db mice. Serum creatinine, creatinine clearance and blood pressure were not affected by administration of dapagliflozin, but glomerular mesangial expansion and interstitial fibrosis were suppressed in a dose-dependent manner. Dapagliflozin treatment markedly decreased macrophage infiltration and the gene expression of inflammation and oxidative stress in the kidney of db/db mice. Moreover, dapagliflozin suppressed the high-glucose-induced gene expression of inflammatory cytokines and oxidative stress in cultured mProx24 cells. These data suggest that dapagliflozin ameliorates diabetic nephropathy by improving hyperglycemia along with inhibiting inflammation and oxidative stress." @default.
• W2023244494 created "2016-06-24" @default.
• W2023244494 creator A5000894769 @default.
• W2023244494 creator A5007240027 @default.
• W2023244494 creator A5007276836 @default.
• W2023244494 creator A5010378457 @default.
• W2023244494 creator A5039655833 @default.
• W2023244494 creator A5049447022 @default.
• W2023244494 creator A5060034527 @default.
• W2023244494 creator A5061756485 @default.
• W2023244494 creator A5065029431 @default.
• W2023244494 creator A5071064609 @default.
• W2023244494 creator A5089180594 @default.
• W2023244494 creator A5091097806 @default.
• W2023244494 date "2014-06-24" @default.
• W2023244494 modified "2023-10-13" @default.
• W2023244494 title "Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice" @default.
• W2023244494 cites W1603802113 @default.
• W2023244494 cites W1974115114 @default.
• W2023244494 cites W1990025047 @default.
• W2023244494 cites W1996854381 @default.
• W2023244494 cites W2051266289 @default.
• W2023244494 cites W2052976889 @default.
• W2023244494 cites W2071477116 @default.
• W2023244494 cites W2085122906 @default.
• W2023244494 cites W2090360729 @default.
• W2023244494 cites W2095574383 @default.
• W2023244494 cites W2097283684 @default.
• W2023244494 cites W2099931326 @default.
• W2023244494 cites W2100650274 @default.
• W2023244494 cites W2105662115 @default.
• W2023244494 cites W2105731956 @default.
• W2023244494 cites W2116197163 @default.
• W2023244494 cites W2120922908 @default.
• W2023244494 cites W2124502714 @default.
• W2023244494 cites W2128814368 @default.
• W2023244494 cites W2130332782 @default.
• W2023244494 cites W2134891317 @default.
• W2023244494 cites W2135152819 @default.
• W2023244494 cites W2138364630 @default.
• W2023244494 cites W2144173715 @default.
• W2023244494 cites W2144664904 @default.
• W2023244494 cites W2148958160 @default.
• W2023244494 cites W2152211669 @default.
• W2023244494 cites W2171553260 @default.
• W2023244494 cites W2171784381 @default.
• W2023244494 cites W2171786511 @default.
• W2023244494 doi "https://doi.org/10.1371/journal.pone.0100777" @default.
• W2023244494 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4069074" @default.
• W2023244494 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24960177" @default.
• W2023244494 hasPublicationYear "2014" @default.
• W2023244494 type Work @default.
• W2023244494 sameAs 2023244494 @default.
• W2023244494 citedByCount "255" @default.
• W2023244494 countsByYear W20232444942014 @default.
• W2023244494 countsByYear W20232444942015 @default.
• W2023244494 countsByYear W20232444942016 @default.
• W2023244494 countsByYear W20232444942017 @default.
• W2023244494 countsByYear W20232444942018 @default.
• W2023244494 countsByYear W20232444942019 @default.
• W2023244494 countsByYear W20232444942020 @default.
• W2023244494 countsByYear W20232444942021 @default.
• W2023244494 countsByYear W20232444942022 @default.
• W2023244494 countsByYear W20232444942023 @default.
• W2023244494 crossrefType "journal-article" @default.
• W2023244494 hasAuthorship W2023244494A5000894769 @default.
• W2023244494 hasAuthorship W2023244494A5007240027 @default.
• W2023244494 hasAuthorship W2023244494A5007276836 @default.
• W2023244494 hasAuthorship W2023244494A5010378457 @default.
• W2023244494 hasAuthorship W2023244494A5039655833 @default.
• W2023244494 hasAuthorship W2023244494A5049447022 @default.
• W2023244494 hasAuthorship W2023244494A5060034527 @default.
• W2023244494 hasAuthorship W2023244494A5061756485 @default.
• W2023244494 hasAuthorship W2023244494A5065029431 @default.
• W2023244494 hasAuthorship W2023244494A5071064609 @default.
• W2023244494 hasAuthorship W2023244494A5089180594 @default.
• W2023244494 hasAuthorship W2023244494A5091097806 @default.
• W2023244494 hasBestOaLocation W20232444941 @default.
• W2023244494 hasConcept C126322002 @default.
• W2023244494 hasConcept C134018914 @default.
• W2023244494 hasConcept C2776151105 @default.
• W2023244494 hasConcept C2776174234 @default.
• W2023244494 hasConcept C2776914184 @default.
• W2023244494 hasConcept C2777180221 @default.
• W2023244494 hasConcept C2777422806 @default.
• W2023244494 hasConcept C2779719074 @default.
• W2023244494 hasConcept C2779770810 @default.
• W2023244494 hasConcept C2779922275 @default.
• W2023244494 hasConcept C2780091579 @default.
• W2023244494 hasConcept C2780306776 @default.
• W2023244494 hasConcept C2780559512 @default.
• W2023244494 hasConcept C2781308076 @default.
• W2023244494 hasConcept C555293320 @default.
• W2023244494 hasConcept C71924100 @default.
• W2023244494 hasConcept C90466245 @default.
• W2023244494 hasConceptScore W2023244494C126322002 @default.
• W2023244494 hasConceptScore W2023244494C134018914 @default.
• W2023244494 hasConceptScore W2023244494C2776151105 @default.

• next